Summary for 6H5F
Entry DOI | 10.2210/pdb6h5f/pdb |
Descriptor | Putative soluble lytic murein transglycosylase (2 entities in total) |
Functional Keywords | peptidoglycan, antibiotic resistance, enzyme hub, transferase |
Biological source | Neisseria meningitidis NM422 |
Total number of polymer chains | 1 |
Total formula weight | 67824.35 |
Authors | Williams, A.H. (deposition date: 2018-07-24, release date: 2019-08-28, Last modification date: 2024-11-13) |
Primary citation | Williams, A.H.,Wheeler, R.,Deghmane, A.E.,Santecchia, I.,Schaub, R.E.,Hicham, S.,Moya Nilges, M.,Malosse, C.,Chamot-Rooke, J.,Haouz, A.,Dillard, J.P.,Robins, W.P.,Taha, M.K.,Gomperts Boneca, I. Defective lytic transglycosylase disrupts cell morphogenesis by hindering cell wall de-O-acetylation inNeisseria meningitidis. Elife, 9:-, 2020 Cited by PubMed Abstract: Lytic transglycosylases (LT) are enzymes involved in peptidoglycan (PG) remodeling. However, their contribution to cell-wall-modifying complexes and their potential as antimicrobial drug targets remains unclear. Here, we determined a high-resolution structure of the LT, an outer membrane lipoprotein from species with a disordered active site helix (alpha helix 30). We show that deletion of the conserved alpha-helix 30 interferes with the integrity of the cell wall, disrupts cell division, cell separation, and impairs the fitness of the human pathogen during infection. Additionally, deletion of alpha-helix 30 results in hyperacetylated PG, suggesting this LtgA variant affects the function of the PG de-acetylase (Ape 1). Our study revealed that Ape 1 requires LtgA for optimal function, demonstrating that LTs can modulate the activity of their protein-binding partner. We show that targeting specific domains in LTs can be lethal, which opens the possibility that LTs are useful drug-targets. PubMed: 32022687DOI: 10.7554/eLife.51247 PDB entries with the same primary citation |
Experimental method | X-RAY DIFFRACTION (2 Å) |
Structure validation
Download full validation report
